Literature DB >> 8765519

Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.

J P Meara1, D H Rich.   

Abstract

Analogs of the epoxysuccinyl peptide cysteine proteinase inhibitor, EP-475 (2a), in which the free carboxylate has been replaced by hydroxamic acid, amide, methyl ketone, hydroxyl, and ethyl ester functionalities, have been synthesized. Individual rate constants of inhibition of papain were determined for these inhibitors. The results show that a carbonyl-containing functionality is necessary for good activity. The pH dependence of the inhibition of papain was determined for a nonionizable EP-475 (2a) analog; inhibition was found to depend on two acidic ionizations (pKas of 3.93 and 4.09) of papain. Implications for the mechanism of action of epoxysuccinyl peptides with papain are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765519     DOI: 10.1021/jm950445b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.

Authors:  Benelita Tina Elie; Vasilena Gocheva; Tanaya Shree; Stacie A Dalrymple; Leslie J Holsinger; Johanna A Joyce
Journal:  Biochimie       Date:  2010-05-04       Impact factor: 4.079

2.  Cathepsin B inhibition limits bone metastasis in breast cancer.

Authors:  Nimali P Withana; Galia Blum; Mansoureh Sameni; Clare Slaney; Arulselvi Anbalagan; Mary B Olive; Bradley N Bidwell; Laura Edgington; Ling Wang; Kamiar Moin; Bonnie F Sloane; Robin L Anderson; Matthew S Bogyo; Belinda S Parker
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

3.  Murine cathepsin F deficiency causes neuronal lipofuscinosis and late-onset neurological disease.

Authors:  Chi-Hui Tang; Je-Wook Lee; Michael G Galvez; Liliane Robillard; Sara E Mole; Harold A Chapman
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

4.  A novel cysteine cathepsin inhibitor yields macrophage cell death and mammary tumor regression.

Authors:  S J Salpeter; Y Pozniak; E Merquiol; Y Ben-Nun; T Geiger; G Blum
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

5.  Inhibition of the purified 20S proteasome by non-heme iron complexes.

Authors:  Jai Prakash; Sara M Schmitt; Q Ping Dou; Jeremy J Kodanko
Journal:  Metallomics       Date:  2011-12-15       Impact factor: 4.526

6.  Examination of the impact molecular charge has on NTSR1-targeted agents incorporated with cysteine protease inhibitors.

Authors:  Wei Fan; Wenting Zhang; Sameer Alshehri; Jered C Garrison
Journal:  Eur J Med Chem       Date:  2022-03-08       Impact factor: 6.514

7.  Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

Authors:  G P Shi; R A Bryant; R Riese; S Verhelst; C Driessen; Z Li; D Bromme; H L Ploegh; H A Chapman
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

Review 8.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

9.  Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer.

Authors:  Nicola R Brindle; Johanna A Joyce; Fanya Rostker; Elizabeth R Lawlor; Lamorna Swigart-Brown; Gerard Evan; Douglas Hanahan; Ksenya Shchors
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

10.  Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation.

Authors:  Ana-Maria Lennon-Duménil; Arnold H Bakker; René Maehr; Edda Fiebiger; Herman S Overkleeft; Mario Rosemblatt; Hidde L Ploegh; Cécile Lagaudrière-Gesbert
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.